184

Technology & AI
Sub Categories on Technology & AI
{{items.name}}
Latest Articles
New method accelerates resistance testing in urinary tract infections

New method accelerates resistance testing in urinary tract infections

byTechnical University MunichTest strips with various uropathogenic bacterial species that are responsible for the majority of urinary tract infections. Credit: Henning Sabersky-Müssigbrodt / TUMResea
Updated on: January 21,2026
New method accelerates resistance testing in urinary tract infections

New method accelerates resistance testing in urinary tract infections

byTechnical University MunichTest strips with various uropathogenic bacterial species that are responsible for the majority of urinary tract infections. Credit: Henning Sabersky-Müssigbrodt / TUMResea
Updated on:January 21,2026
Patient-specific human liver model lays foundation for personalized treatments

Patient-specific human liver model lays foundation for personalized treatments

byMax Planck SocietyHuman periportal assembloid, showcasing the three key cell types of the liver: portal fibroblasts (magenta), cholangiocytes (green), and hepatocyte nuclei (blue). All cell borders
Updated on: January 24,2026
Patient-specific human liver model lays foundation for personalized treatments

Patient-specific human liver model lays foundation for personalized treatments

byMax Planck SocietyHuman periportal assembloid, showcasing the three key cell types of the liver: portal fibroblasts (magenta), cholangiocytes (green), and hepatocyte nuclei (blue). All cell borders
Updated on:January 24,2026
AI can detect early signs of aging from chest X-rays

AI can detect early signs of aging from chest X-rays

byHinda and Arthur Marcus Institute for Aging ResearchCredit: Pixabay/CC0 Public DomainArtificial intelligence may be able to reveal how fast your body is aging by analyzing a chest X-ray, according t
Updated on: January 05,2026
AI can detect early signs of aging from chest X-rays

AI can detect early signs of aging from chest X-rays

byHinda and Arthur Marcus Institute for Aging ResearchCredit: Pixabay/CC0 Public DomainArtificial intelligence may be able to reveal how fast your body is aging by analyzing a chest X-ray, according t
Updated on:January 05,2026
New video dataset captures human dynamics of care, advancing AI for health care

New video dataset captures human dynamics of care, advancing AI for health care

byUniversity of PennsylvaniaA sample, anonymized recording from the Observer dataset. Credit: Artificial Intelligence for Ambulatory Care Innovation (AI-4-AI) Lab, Penn Sample room configurations of p
Updated on: January 05,2026
New video dataset captures human dynamics of care, advancing AI for health care

New video dataset captures human dynamics of care, advancing AI for health care

byUniversity of PennsylvaniaA sample, anonymized recording from the Observer dataset. Credit: Artificial Intelligence for Ambulatory Care Innovation (AI-4-AI) Lab, Penn Sample room configurations of p
Updated on:January 05,2026
AI for Predicting Resistance in Gram-Negative Bloodstream Infections: A New Frontier in Sepsis Management

AI for Predicting Resistance in Gram-Negative Bloodstream Infections: A New Frontier in Sepsis Management

Gram-negative bloodstream infections (GN-BSI) remain among the most severe and lethal infectious diseases, particularly in intensive care units and regions where multidrug resistance (MDR) is endemic.
Updated on: July 07,2025
AI for Predicting Resistance in Gram-Negative Bloodstream Infections: A New Frontier in Sepsis Management

AI for Predicting Resistance in Gram-Negative Bloodstream Infections: A New Frontier in Sepsis Management

Gram-negative bloodstream infections (GN-BSI) remain among the most severe and lethal infectious diseases, particularly in intensive care units and regions where multidrug resistance (MDR) is endemic.
Updated on:July 07,2025
Weekly Update of Drug News-4/9/2025

Weekly Update of Drug News-4/9/2025

On Aug 21, 2025, Abbvie announced that positive results from study 1 of the Phase 3 UP-AA clinical program evaluating the safety and efficacy of RINVOQ® (Upadacitinib) in adult and adolescent patients with severe alopecia areata (AA) with a mean baseline
Updated on: September 04,2025
Weekly Update of Drug News-4/9/2025

Weekly Update of Drug News-4/9/2025

On Aug 21, 2025, Abbvie announced that positive results from study 1 of the Phase 3 UP-AA clinical program evaluating the safety and efficacy of RINVOQ® (Upadacitinib) in adult and adolescent patients with severe alopecia areata (AA) with a mean baseline
Updated on:September 04,2025
More News
Categories
Allergy&Clinical immunology
Anesthesiology & Pain
Cardiovascular Diseases
Dermatology
Diabetes & Endocrinology
Emergency Medicine & Critical Care
ENT & HN
Family Medicine
Gastroenterology
General Surgery
Geriatrics
Hematology&Oncology
Infectious Diseases
Nephrology & Urology
Neurology
Nutrition
OB & GYN
Ophthalmology
Orthopedics & Sports medicine
Pediatrics
Plastic Surgery
Psychiatry & Mental Health
Public Health & Prevention
Pulmonology
Rheumatology
Stomatology
Sleep
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com